Central Venous Catheter Market By Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Central Venous Catheter Market
Central Venous Catheter Market: By Type (Peripherally Inserted, Tunnelled, & Non- Tunnelled), By Procedure (Cardiovascular, Chemotherapy & Dialysis) & By Geography-Forecast (2016-2021)
Report Code : CMR 0359
Updated Date: 25 February, 2016  
4

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Customization Options
A central venous catheter, also referred as central line. Central venous catheter is inserted into large vein in the neck, or chest to monitor cardiovascular health of the patient or to give medicines, fluids, nutrients, or blood products when the patient under observation is suffering with diseases such as cancer, cardiovascular diseases, and renal failure and traditional way of providing medicines or nutrients is not working.

This report identifies the central venous catheter market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to central venous catheter market.
 
Central Venous Catheter Market

Globally North America dominated the market for central venous catheter in 2015 followed by Europe as second largest regional market. Major factor behind dominance of these two regions in central venous catheter market place are estimated to be high reported cases of cardiac and cancer related diseases well as well-established healthcare infrastructure equipped with advanced machines and equipment in these regions. Asia- Pacific is expected to witness strong growth in the central venous catheter market during the period of study due to increasing reported instances of the cardiac and cancer disease coupled with increasing awareness and rapidly developing healthcare infrastructure in the region especially in major developing economies like India and China.

This report on central venous catheter also covers different type central venous catheter, major procedure performed by central venous catheter and market size in various geographical regions.
  • The report covers major types of central venous catheter, some of the major central venous catheter types are as follows: Peripherally inserted central catheters (PICC), Tunnelled Central Venous Catheter and Non-Tunnelled Central Venous Catheter
  • This report also identifies major procedures performed by central venous catheter, some of the major procedures covered in this report are as follows: Cardiovascular procedures, Chemotherapy procedures and Dialysis procedures
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for central venous catheter in each of the region.

This report identifies all the major companies operating in the central venous catheter market. Some of the major companies’ profiles in detail are as follows:
  • Becton Dickinson Company
  • Edwards Life sciences Corporation
  • B.Braun Melsungen AG     
  • C. R. Bard Inc    
  • Terumo Corporation
1. Central Venous Catheter – Market Overview
2. Executive Summary
3. Central Venous Catheter Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Central Venous Catheter – Market Forces
   4.1. Drivers
      4.1.1. Increasing global population with cardiac and cancerous diseases
      4.1.2. Developing healthcare infrastructure in emerging nations
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Central Venous Catheter Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Central Venous Catheter Market, By Type
   6.1. Peripherally inserted central catheters (PICC)
   6.2. Tunnelled Central Venous Catheter
   6.3. Non-Tunnelled Central Venous Catheter
7. Central Venous Catheter Market By Procedure
   7.1. Cardiovascular procedures
   7.2. Chemotherapy procedures
   7.3. Dialysis procedures
8. Central Venous Catheter Market By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Central Venous Catheter – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles
   10.1. Becton Dickinson Company
      10.1.1.  Introduction
      10.1.2. Financials
      10.1.3. Key Insights
      10.1.4. Key Strategy
      10.1.5. Product Portfolio
      10.1.6. SWOT Analysis
   10.2. Edwards Life sciences Corporation
      10.2.1. Introduction
      10.2.2. Financials
      10.2.3. Key Insights
      10.2.4. Key Strategy
      10.2.5. Product Portfolio
      10.2.6. SWOT Analysis
   10.3. B.Braun Melsungen AG     
      10.3.1.  Introduction
      10.3.2. Financials
      10.3.3. Key Insights
      10.3.4. Key Strategy
      10.3.5. Product Portfolio
      10.3.6. SWOT Analysis
   10.4. C. R. Bard Inc    
      10.4.1. Introduction
      10.4.2. Financials
      10.4.3. Key Insights
      10.4.4. Key Strategy
      10.4.5. Product Portfolio
      10.4.6. SWOT Analysis
   10.5. Terumo Corporation  
      10.5.1. Introduction
      10.5.2. Financials
      10.5.3. Key Insights
      10.5.4. Key Strategy
      10.5.5. Product Portfolio
      10.5.6. SWOT Analysis
   10.6. Smiths Medical    
      10.6.1. Introduction
      10.6.2. Financials
      10.6.3. Key Insights
      10.6.4. Key Strategy
      10.6.5. Product Portfolio
      10.6.6. SWOT Analysis
   10.7. Teleflex Incorporated
      10.7.1. Introduction
      10.7.2. Financials
      10.7.3. Key Insights
      10.7.4. Key Strategy
      10.7.5. Product Portfolio
      10.7.6. SWOT Analysis
   10.8. Johnson and Johnson
      10.8.1. Introduction
      10.8.2. Financials
      10.8.3. Key Insights
      10.8.4. Key Strategy
      10.8.5. Product Portfolio
      10.8.6. SWOT Analysis
   10.9. Rochester Medical Co
      10.9.1. Introduction
      10.9.2. Financials
      10.9.3. Key Insights
      10.9.4. Key Strategy
      10.9.5. Product Portfolio
      10.9.6. SWOT Analysis
   10.10. Medrad (Bayer AG)
      10.10.1. Introduction
      10.10.2. Financials
      10.10.3. Key Insights
      10.10.4. Key Strategy
      10.10.5. Product Portfolio
      10.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Expert Insights
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll